Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Anticoagulants, such as dalteparin, may help prevent blood clots from forming in patients
being treated with gemcitabine for pancreatic cancer.
PURPOSE: This randomized phase II trial is studying how well gemcitabine works with or
without dalteparin in treating patients with locally advanced or metastatic pancreatic
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Hull and East Yorkshire Hospitals NHS Trust Hull University Teaching Hospitals NHS Trust